[1] 张斯钰, 罗普泉, 高立冬. 中国重点新发传染病的流行现状与应对策略[J]. 中华疾病控制杂志, 2012, 16(10): 892-896.
[2] 李颖婷, 谢剑锋, 郑奎城. 甲型H1N1流感病毒分子流行病学研究进展[J]. 海峡预防医学杂志, 2015, 21(2): 20-24.
[3] 张文强, 宋绍霞, 王同展. 甲型H1N1流感病毒HA蛋白结构和功能研究进展[J]. 病毒学报, 2012, 6(4): 444-452.
[4] 李宁. 甲型H1N1流感危重症临床诊断与治疗[M]. 北京:人民卫生出版社,2011:99.
[5] Rotrosen, E.T, K.M. Neuzil. Influenza: A Global Perspective[J]. Pediatr Clin North Am, 2017, 64(4): 911-936.
[6] 徐喜卿,李顺平. 我国甲型H1N1流感疫苗免疫效果评估系统综述[J]. 实用预防医学, 2016. 23(4): 506-509.
[7] 夏洪波,陈珺汝,郭锦锦,等. 儿童新甲型(H1N1)流感疫苗接种后远期抗体水平分析[J]. 职业卫生与应急救援, 2017, 35(3): 255-256.
[8] Mossad S.B.The resurgence of swine-origin influenza A (H1N1)[J]. Cleveland Clinic Journal of Medicine, 2009, 76(6): 337-343.
[9] 申学基,李成德,刘健,等. 甲型流感患者感染初期血常规分析及临床意义[J]. 实验与检验医学, 2016, 34(5): 663-665.
[10] Chauhan N, J Narang, S Pundir, et al. Laboratory diagnosis of swine flu: a review[J]. Artif Cells Nanomed Biotechnol, 2013, 41(3):189-195.
[11] Gordon A, A Reingold. The Burden of Influenza: a Complex Problem[J]. Curr Epidemiol Rep, 2018, 5(1): 1-9.
[12] Alame M M, E Massaad, H Zaraket. Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections[J]. Front Microbiol, 2016, 7: 450.
[13] Zhou H, Y Huang, S Yuan. Sequential immunization with consensus influenza hemagglutinins raises cross-reactive neutralizing antibodies against various heterologous HA strains[J]. Vaccine, 2017, 35(2): 305-312. |
